Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study.

Mili FD, Allen T, Wadell PW, Hooper WC, Staercke C, Bean CJ, Lally C, Austin H, Wenger NK.

Future Cardiol. 2018 Jan;14(1):15-26. doi: 10.2217/fca-2017-0025. Epub 2017 Dec 8.

PMID:
29218998
2.

Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.

Deguchi H, Navarro S, Payne AB, Elias DJ, Dowling NF, Austin HD, España F, Medina P, Hooper WC, Griffin JH.

Res Pract Thromb Haemost. 2017 Jul;1(1):33-40. doi: 10.1002/rth2.12018. Epub 2017 Jun 23.

3.

Strategies and partnerships toward prevention of Healthcare-Associated Venous Thromboembolism.

Beckman MG, Abe K, Barnes K, Bartman B, Brady PJ, Hooper WC.

J Hosp Med. 2016 Dec;11 Suppl 2:S5-S7. doi: 10.1002/jhm.2659. Review. No abstract available.

4.

Cluster of inhibitors among adult inpatients with haemophilia in a single institution.

Ishaku NG, Key NS, Miller CH, Nielsen B, Buckner T, Chen SL, Hooper WC, Soucie JM.

Haemophilia. 2015 Jul;21(4):e325-8. doi: 10.1111/hae.12697. Epub 2015 May 4. No abstract available.

PMID:
25939561
5.

Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism.

Lewis DA, Suchindran S, Beckman MG, Hooper WC, Grant AM, Heit JA, Manco-Johnson M, Moll S, Philipp CS, Kenney K, De Staercke C, Pyle ME, Chi JT, Ortel TL.

Thromb Res. 2015 Apr;135(4):659-65. doi: 10.1016/j.thromres.2015.02.003. Epub 2015 Feb 7.

6.

Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.

Yusuf HR, Hooper WC, Grosse SD, Parker CS, Boulet SL, Ortel TL.

Thromb Res. 2015 Jan;135(1):50-7. doi: 10.1016/j.thromres.2014.10.012. Epub 2014 Oct 22.

7.

In reply.

Tepper NK, Boulet SL, Whiteman MK, Monsour M, Marchbanks PA, Hooper WC, Curtis KM.

Obstet Gynecol. 2014 Oct;124(4):838-9. doi: 10.1097/AOG.0000000000000486. No abstract available.

PMID:
25244449
8.

Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.

Rahman AM, Murrow JR, Ozkor MA, Kavtaradze N, Lin J, De Staercke C, Hooper WC, Manatunga A, Hayek S, Quyyumi AA.

J Vasc Res. 2014;51(3):200-8. doi: 10.1159/000362666. Epub 2014 Jun 4.

9.

Females with FVIII and FIX deficiency have reduced joint range of motion.

Sidonio RF, Mili FD, Li T, Miller CH, Hooper WC, DeBaun MR, Soucie M; Hemophilia Treatment Centers Network.

Am J Hematol. 2014 Aug;89(8):831-6. doi: 10.1002/ajh.23754. Epub 2014 May 21.

10.

High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.

Payne AB, Miller CH, Hooper WC, Lally C, Austin HD.

Ethn Dis. 2014 Spring;24(2):169-74.

11.

Postpartum venous thromboembolism: incidence and risk factors.

Tepper NK, Boulet SL, Whiteman MK, Monsour M, Marchbanks PA, Hooper WC, Curtis KM.

Obstet Gynecol. 2014 May;123(5):987-96. doi: 10.1097/AOG.0000000000000230.

PMID:
24785851
12.

Discordance between self-report and genetic confirmation of sickle cell disease status in African-American adults.

Bean CJ, Hooper WC, Ellingsen D, DeBaun MR, Sonderman J, Blot WJ.

Public Health Genomics. 2014;17(3):169-72. doi: 10.1159/000360260. Epub 2014 Mar 28.

13.

Prothrombin G20210A mutation is associated with young-onset stroke: the genetics of early-onset stroke study and meta-analysis.

Jiang B, Ryan KA, Hamedani A, Cheng Y, Sparks MJ, Koontz D, Bean CJ, Gallagher M, Hooper WC, McArdle PF, O'Connell JR, Stine OC, Wozniak MA, Stern BJ, Mitchell BD, Kittner SJ, Cole JW.

Stroke. 2014 Apr;45(4):961-7. doi: 10.1161/STROKEAHA.113.004063. Epub 2014 Mar 11.

14.

Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.

Yusuf HR, Hooper WC, Beckman MG, Zhang QC, Tsai J, Ortel TL.

J Thromb Thrombolysis. 2014 Oct;38(3):306-13. doi: 10.1007/s11239-014-1050-0.

15.

Mutation analysis of a cohort of US patients with hemophilia B.

Li T, Miller CH, Driggers J, Payne AB, Ellingsen D, Hooper WC.

Am J Hematol. 2014 Apr;89(4):375-9. doi: 10.1002/ajh.23645. Epub 2014 Mar 3.

16.

Seroepidemiologic survey of epidemic cholera in Haiti to assess spectrum of illness and risk factors for severe disease.

Jackson BR, Talkington DF, Pruckler JM, Fouché MD, Lafosse E, Nygren B, Gómez GA, Dahourou GA, Archer WR, Payne AB, Hooper WC, Tappero JW, Derado G, Magloire R, Gerner-Smidt P, Freeman N, Boncy J, Mintz ED; Cholera Serosurvey Working Group.

Am J Trop Med Hyg. 2013 Oct;89(4):654-64. doi: 10.4269/ajtmh.13-0208.

17.

Physiological functions and clinical implications of fibrinogen-like 2: A review.

Yang G, Hooper WC.

World J Clin Infect Dis. 2013 Aug 25;3(3):37-46.

18.

Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia.

Bean CJ, Boulet SL, Yang G, Payne AB, Ghaji N, Pyle ME, Hooper WC, Bhatnagar P, Keefer J, Barron-Casella EA, Casella JF, Debaun MR.

Br J Haematol. 2013 Oct;163(2):268-76. doi: 10.1111/bjh.12507. Epub 2013 Aug 16.

19.

Predictive accuracy of 29-comorbidity index for in-hospital deaths in US adult hospitalizations with a diagnosis of venous thromboembolism.

Tsai J, Abe K, Boulet SL, Beckman MG, Hooper WC, Grant AM.

PLoS One. 2013 Jul 26;8(7):e70061. doi: 10.1371/journal.pone.0070061. Print 2013.

20.

Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.

Payne AB, Link-Gelles R, Azonobi I, Hooper WC, Beall BW, Jorgensen JH, Juni B, Moore M; Active Bacterial Core Surveillance Team.

Pediatr Infect Dis J. 2013 Dec;32(12):1308-12. doi: 10.1097/INF.0b013e3182a11808.

Supplemental Content

Loading ...
Support Center